Purpose: To investigate if specific exon 38 or 39 KMT2D missense variants (MVs) cause a condition distinct from Kabuki syndrome type 1 (KS1). Methods: Multiple individuals, with MVs in exons 38 or 39 of KMT2D that encode a highly conserved region of 54 amino acids flanked by Val3527 and Lys3583, were identified and phenotyped. Functional tests were performed to study their pathogenicity and understand the disease mechanism. Results: The consistent clinical features of the affected individuals, from seven unrelated families, included choanal atresia, athelia or hypoplastic nipples, branchial sinus abnormalities, neck pits, lacrimal duct anomalies, hearing loss, external ear malformations, and thyroid abnormalities. None of the individuals had intellectual disability. The frequency of clinical features, objective software-based facial analysis metrics, and genome-wide peripheral blood DNA methylation patterns in these patients were significantly different from that of KS1. Circular dichroism spectroscopy indicated that these MVs perturb KMT2D secondary structure through an increased disordered to ɑ-helical transition. Conclusion: KMT2D MVs located in a specific region spanning exons 38 and 39 and affecting highly conserved residues cause a novel multiple malformations syndrome distinct from KS1. Unlike KMT2D haploinsufficiency in KS1, these MVs likely result in disease through a dominant negative mechanism.

A restricted spectrum of missense KMT2D variants cause a multiple malformations disorder distinct from Kabuki syndrome / Cuvertino S.; Hartill V.; Colyer A.; Garner T.; Nair N.; Al-Gazali L.; Canham N.; Faundes V.; Flinter F.; Hertecant J.; Holder-Espinasse M.; Jackson B.; Lynch S.A.; Nadat F.; Narasimhan V.M.; Peckham M.; Sellers R.; Seri M.; Montanari F.; Southgate L.; Squeo G.M.; Trembath R.; van Heel D.; Venuto S.; Weisberg D.; Stals K.; Ellard S.; Barton A.; Kimber S.J.; Sheridan E.; Merla G.; Stevens A.; Johnson C.A.; Banka S.. - In: GENETICS IN MEDICINE. - ISSN 1098-3600. - ELETTRONICO. - 22:5(2020), pp. 867-877. [10.1038/s41436-019-0743-3]

A restricted spectrum of missense KMT2D variants cause a multiple malformations disorder distinct from Kabuki syndrome

Seri M.;Montanari F.;
2020

Abstract

Purpose: To investigate if specific exon 38 or 39 KMT2D missense variants (MVs) cause a condition distinct from Kabuki syndrome type 1 (KS1). Methods: Multiple individuals, with MVs in exons 38 or 39 of KMT2D that encode a highly conserved region of 54 amino acids flanked by Val3527 and Lys3583, were identified and phenotyped. Functional tests were performed to study their pathogenicity and understand the disease mechanism. Results: The consistent clinical features of the affected individuals, from seven unrelated families, included choanal atresia, athelia or hypoplastic nipples, branchial sinus abnormalities, neck pits, lacrimal duct anomalies, hearing loss, external ear malformations, and thyroid abnormalities. None of the individuals had intellectual disability. The frequency of clinical features, objective software-based facial analysis metrics, and genome-wide peripheral blood DNA methylation patterns in these patients were significantly different from that of KS1. Circular dichroism spectroscopy indicated that these MVs perturb KMT2D secondary structure through an increased disordered to ɑ-helical transition. Conclusion: KMT2D MVs located in a specific region spanning exons 38 and 39 and affecting highly conserved residues cause a novel multiple malformations syndrome distinct from KS1. Unlike KMT2D haploinsufficiency in KS1, these MVs likely result in disease through a dominant negative mechanism.
2020
A restricted spectrum of missense KMT2D variants cause a multiple malformations disorder distinct from Kabuki syndrome / Cuvertino S.; Hartill V.; Colyer A.; Garner T.; Nair N.; Al-Gazali L.; Canham N.; Faundes V.; Flinter F.; Hertecant J.; Holder-Espinasse M.; Jackson B.; Lynch S.A.; Nadat F.; Narasimhan V.M.; Peckham M.; Sellers R.; Seri M.; Montanari F.; Southgate L.; Squeo G.M.; Trembath R.; van Heel D.; Venuto S.; Weisberg D.; Stals K.; Ellard S.; Barton A.; Kimber S.J.; Sheridan E.; Merla G.; Stevens A.; Johnson C.A.; Banka S.. - In: GENETICS IN MEDICINE. - ISSN 1098-3600. - ELETTRONICO. - 22:5(2020), pp. 867-877. [10.1038/s41436-019-0743-3]
Cuvertino S.; Hartill V.; Colyer A.; Garner T.; Nair N.; Al-Gazali L.; Canham N.; Faundes V.; Flinter F.; Hertecant J.; Holder-Espinasse M.; Jackson B.; Lynch S.A.; Nadat F.; Narasimhan V.M.; Peckham M.; Sellers R.; Seri M.; Montanari F.; Southgate L.; Squeo G.M.; Trembath R.; van Heel D.; Venuto S.; Weisberg D.; Stals K.; Ellard S.; Barton A.; Kimber S.J.; Sheridan E.; Merla G.; Stevens A.; Johnson C.A.; Banka S.
File in questo prodotto:
File Dimensione Formato  
s41436-019-0743-3.pdf

accesso aperto

Tipo: Versione (PDF) editoriale
Licenza: Licenza per Accesso Aperto. Creative Commons Attribuzione (CCBY)
Dimensione 1.56 MB
Formato Adobe PDF
1.56 MB Adobe PDF Visualizza/Apri
41436_2019_743_MOESM1_ESM.docx

accesso aperto

Tipo: File Supplementare
Licenza: Licenza per Accesso Aperto. Creative Commons Attribuzione (CCBY)
Dimensione 1.41 MB
Formato Microsoft Word XML
1.41 MB Microsoft Word XML Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/740276
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 21
  • Scopus 36
  • ???jsp.display-item.citation.isi??? 36
social impact